According to a new report, published by KBV research, The Global Metabolism Assays Market size is expected to reach $2.5 Billion by 2030, rising at a market growth of 7.7% CAGR during the forecast period.
The Assay Kits & Reagents segment is leading the Global Metabolism Assays Market by Product in 2022; thereby, achieving a market value of $1.5 billion by 2030. Assay kits and reagents play a vital role in conducting metabolism assays. These kits contain pre-packaged reagents and protocols, simplifying the measurement of specific metabolic parameters and biomolecules. They are essential tools for researchers, clinicians, and laboratory technicians involved in metabolic studies, diagnostics, and research. These kits measure glucose levels in biological samples such as blood, serum, plasma, or cell lysates.
The Research segment is experiencing a CAGR of 9.8% during (2023 - 2030). Research applications in the metabolism assays market are essential for advancing the understanding of metabolic processes, investigating metabolic disorders, and developing new therapies and interventions. Metabolism assays are valuable tools for researchers in various fields, including biochemistry, molecular biology, physiology, and medicine. Researchers use metabolism assays to investigate specific metabolic pathways, including glycolysis, gluconeogenesis, the citric acid cycle, and oxidative phosphorylation.
The Colorimetry segment is generating the maximum revenue in the Global Metabolism Assays Market by Technology in 2022; thereby, achieving a market value of $1.1 billion by 2030. Colorimetry technology is a widely used analytical technique in the metabolism assays market, particularly for quantitatively measuring metabolic parameters and biomolecules. Colorimetry relies on detecting changes in the color of a solution or sample, which occur due to specific chemical reactions between reagents and target molecules.
The Diagnostics Laboratories segment would exhibit a CAGR of 7.9% during (2023 - 2030). Metabolism assays are valuable tools in diagnostics laboratories to assess, diagnose, and monitor various metabolic disorders and conditions. These assays provide critical information about the metabolic status of patients, aiding healthcare professionals in making accurate diagnoses and treatment decisions.
The North America region dominated the Global Metabolism Assays Market by Region in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $899.8 million by 2030. The Europe region is poised to grow at a CAGR of 7.3% during (2023 - 2030). Additionally, The Asia Pacific region would witness a CAGR of 8.4% during (2023 - 2030).
Full Report: https://www.kbvresearch.com/metabolism-assays-market/
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Merck KGaA, Thermo Fisher Scientific, Inc., Abcam Plc, Agilent Technologies, Inc, Promega Corporation, Kaneka Eurogentec S.A (Kaneka Corporation), RayBiotech Life, Inc, Sartorius AG, Elabscience Biotechnology Inc. and Bmg Labtech GmbH.
By Product
By Application
By Technology
By End User
By Geography
Companies Profiled
Unique Offerings 
